Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF)

NACompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Heart FailureAtrial Fibrillation
Interventions
PROCEDURE

AV nodal ablation

Percutaneous catheter ablation of the AV node.

DRUG

Medical Ventricular Rate Control

Ventricular Rate Control with target ventricular rate of 90 beats per minute.

Trial Locations (33)

1142

Auckland City Hospital, Auckland

2031

Prince of Wales Hospital, Randwick

2065

Royal North Shore Hospital, Sydney

2305

John Hunter Hospital, New Lambton

2605

Canberra Hospital, Canberra

3050

Royal Melbourne Hospital, Parkville

3084

Austin Hospital, Heidelberg

3143

Tauranga Hospital, Tauranga

3168

Monash Medical Centre, Clayton

3220

Geelong Hospital, Geelong

3240

Waikato Hospital, Hamilton

4032

Prince Charles Hospital, Chermside

4102

Princess Alexandra Hospital, Woolloongabba

4209

Royal Brisbane Hospital, Brisbane

4213

Gold Coast University Hospital, Southport

4814

Townsville Hospital and Health Service, Douglas

5000

Royal Adelaide Hospital, Adelaide

5042

Flinders Medical Centre, Bedford Park

6009

Sir Charles Gairdner Hospital, Perth

6021

Wellington Hospital, Wellington

6150

Fiona Stanley, Murdoch

7000

Royal Hobart Hospital, Hobart

20099

Asklepios Hospital, St. Georg

20246

Universitätsklinikum Hamburg-Eppendorf, Hamburg

50400

National Heart Institute, Kuala Lumpur

55131

Universitätsmedizin Mainz, Mainz

Unknown

Concord Hospital, Concord

Royal Prince Alfred Hospital, Sydney

Melbourne Private Hospital, Melbourne

The Alfred Hospital, Melbourne

Royal Perth Hospital, Perth

James Cook University Hospital, Middlesbrough

D-50936

University Clinic of Cologne, Cologne

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Boston Scientific Corporation

INDUSTRY

lead

University of Adelaide

OTHER

NCT01522898 - Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF) | Biotech Hunter | Biotech Hunter